Intersection of addiction, HIV prevention and care focus of May 2026 Consortium Meeting

Community Presentation of San Francisco’s 2024 HIV, HCV, and STI epidemiology data
April 17, 2026
Just as SF was getting to zero, HIV money started drying up
June 18, 2026
Show all

Intersection of addiction, HIV prevention and care focus of May 2026 Consortium Meeting

At this meeting, Jonathan Frochtzwajg, SFAF Director of Health Justice, updated the group on the latest local, state and national health policy developments, including:

  • The statewide End the Epidemics coalition is advocating for ADAP rebate and opioid settlement funds to be invested in HIV/syndemic services like PrEP navigation, HIV linkage to care, HIV-and-aging services, HIV/HCV/syph screening in EDs, HIV housing, drug checking, and harm reduction programs. ETE is developing ADAP Funds 5-Year Plan & welcomes GTZ-SF’s feedback.
  • Senate Bill 1023, which would require insurers that cover injectable PrEP under their medical benefit to also cover it under their pharmacy benefit
  • Assembly Bill 1843 would prohibit insurers from imposing prior authorization on HCV treatment in most cases, and require PA criteria to align with clinical guidelines
  • Closely monitoring CA implementation of HR 1 to ensure state exempt PLWH from work-reporting requirements.
  • For 2025-26, SFDPH cut more than $938k for syndemic services. For 2026-28, in addition to internal staff reductions, DPH has proposed approx. $3M in reductions to funding for syndemic services. Take Action! Text FIGHT CUTS to the number 1-888-272-2848.

To stay in the know about state issues and take action, text FUND HEALTH to 888-27-ACTIVATE (888-272-2848)

Following that informative update, Dr. Phillip Coffin presented the latest advances in drug treatment and research. We then heard from an esteemed panel – Kyle Temple, LCSW (SFAF); Matt Hickey, MD (UCSF); and Joanna Eveland, MD (SFDPH) – on their insights into the intersection of addiction, HIV prevention, and care.

What’s working

  • Low‑barrier, drop‑in HIV care is highly effective (e.g., Ward 86 POP-UP and CARES)
  • Co‑locating HIV care, substance use treatment (including MOUD), mental health care, and STI/PrEP services in the same space is increasing engagement and retention
  • Long‑acting injectables are “game changers” i.e., buprenorphine, naltrexone, ART
  • Housing First. Getting PEH into shelter or, ideally, permanent supportive housing is essential for stabilizing substance use and improving HIV outcomes
  • Incentives and basic supports increase engagement (e.g., gift cards and snacks)

Some recommendations

  • Scale up low‑barrier, integrated care models
  • Expand long‑acting injectable treatments
  • Invest in supportive housing, shelter with services, and consistent food support
  • Embed harm reduction into all programs. Normalize naloxone, fentanyl test strips, safer use supplies, statins, sleep support, and smoking cessation when talking with patients
  • Train and hire from highly impacted communities to deliver care to build a representative, lived‑experience workforce

Slides from the meeting are here.

Comments are closed.